|
|
|
| home > white papers > Translating Cancer Genomics Into A Personalised Approach For Cancer Patients - PRA Health Sciences (PRA) |
|
|
 WHITE PAPERS |
|
PRA Health Sciences (PRA)
|
|
Translating Cancer Genomics Into A Personalised Approach For Cancer Patients
|
|
Over the past few decades, the approach to prevention, diagnosis and
treatment of cancer has radically shifted from organ-based to
morphology-based and most recently, to genetics-based. Personalized or
precision medicine (tailoring a treatment for a patient’s particular
disease at a precise time point) is being performed every day at
different levels in the clinical setting.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
SGS Enrolls First Patient into Biophytis’ COVA Clinical Study, a COVID-19 Clinical Trial
SGS was chosen by French biotech company Biophytis to conduct its COVA
study – a Clinical Trial with Sarconeos (BIO101) for the Treatment of
Patients with COVID-19 Related Respiratory Failure.
More info >> |
|
 |
White Papers |
 |
|
Nasal Drug Delivery with a Focus on Chronic Rhino-Sinusitis
Aptar Pharma
Aptar Pharma have hosted a scientific roundtable on “Nasal drug delivery
with a focus on chronic rhino‑sinusitis”. This international scientific
forum was held in Paris, France on November 13th 2012. The roundtable
was organized to explore and exchange views on the science of various
forms of sinusitis and its related unmet medical needs.
More info >> |
|
 |
Industry Events |
 |
Outsourcing in Clinical Trials Europe
26-27 October 2020, Paris, France
Arena International are delighted to announce the return of Outsourcing
in Clinical Trials Europe. Part of our global series of events, this
flagship show will attract the leading clinical professionals from
across Europe. The 10th Annual event will be hosted in Paris.
More info >> |
|
|
|
.jpg)
